| Financial Year |
September 30 2019 |
| Monetary Funds |
19,185,663,034.98 |
| Held-for-trading Financial Assets |
5,264,515,959.78 |
| Notes Receivable |
-- |
| Accounts Receivable |
330,455,138.53 |
| Advances to Suppliers |
88,404,964.46 |
| Other Receivables |
3,996,393,505.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
12,739,920.03 |
| Dividend Receivable |
-- |
| Inventories |
146,630,727.67 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,795,083,165.92 |
| Total Current Assets |
48,085,086,069.88 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
460,512,132.49 |
| Investment Properties |
-- |
| Fixed Assetes |
1,602,461,366.72 |
| Under-construction Projects |
7,289,176.83 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
59,885,544.10 |
| R&D expenses |
-- |
| Goodwill |
2,953,945,474.64 |
| Long-Term Deferred and Prepaid Expenses |
79,888,624.54 |
| Deferred Income Tax Assets |
66,039,176.00 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
5,247,310,795.36 |
| Total Assets |
53,332,396,865.24 |
| Short-Term Loans |
896,464,752.97 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
110,201,925.67 |
| Accounts Received In Advance |
131,151,099.16 |
| Employee Compensation Payable |
128,621,987.01 |
| Taxes Payable |
106,817,011.93 |
| Interest Payable |
1,709,089.12 |
| Dividend Payable |
-- |
| Other payables |
897,851,085.36 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
711,176,019.77 |
| Other Current Liabilities |
2,468,879,017.70 |
| Sub-Total of Current Liabilities |
31,332,942,456.68 |
| Long-term Loans |
-- |
| Bonds Payable |
1,205,187,455.96 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
15,728,170.28 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,222,445,916.81 |
| Total Liabilities |
32,555,388,373.49 |
| Paid-In Capital(Or Share Stock) |
6,715,608,655.00 |
| Capital Surplus |
8,929,611,963.88 |
| Surplus Reserve |
398,475,143.96 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,721,435,677.25 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
20,777,008,491.75 |
| Owner's Equity（Stockholder's Equity） |
20,777,008,491.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
53,332,396,865.24 |
